## Abstract Teicoplanin pharmacokinetics were investigated upon multiple dose intravenous administration of 6 and 12 mg kg^β1^ in 10 normal, healthy, male volunteers, using a twoβperiod, randomized, crossover design; six subjects completed both periods. On day 1, 6 or 12 mg kg^β1^ was administered
Multiple dose pharmacokinetics of caffeine administered in chewing gum to normal healthy volunteers
β Scribed by Shariq A. Syed; Gary H. Kamimori; William Kelly; Natalie D. Eddington
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 99 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.469
No coin nor oath required. For personal study only.
β¦ Synopsis
The purpose of this study was to examine the pharmacokinetics of three doses of caffeine administered as Stay Alert chewing gum in a multiple dose regimen.
Methods:
A double-blind, parallel randomized, four-treatment study design was employed. the treatment groups were: 50, 100 and 200 mg caffeine and placebo. subjects were 48 (n = 12 per group), healthy, non-smoking, males and females who had abstained from caffeine ingestion for at least 20 h prior to dosing, who were randomly assigned to the treatment groups. caffeine was administered at 2,400, 0200 and 0400 h depending on the treatment group. blood samples were collected pre-dose and at 5, 15, 30, 45, 60, 75, 90 and 105 min after each caffeine dose. samples were also collected at 7.5, 8.5 and 18 h after the last dose of caffeine. plasma caffeine levels were analysed by a validated uv-hplc method.
Result:
The mean t(max) after the third dosing ranged from 0.37 to 1.12 h. c(max) for 50, 100 and 200 mg was 2.69, 3.45 and 6.33 mg/l, respectively. auc(inf) for 50, 100 and 200 mg group was 33.2, 46.94 and 86.94 mg/l * h, respectively. auc(inf) values suggested a dose proportionate increase. dose normalized c(max) and auc(0-tau) values across doses were not significantly different, suggesting linearity was maintained after multiple doses of the stay alert chewing gum. there were no group related differences in elimination.
Conclusions:
The results suggest that caffeine administered in the gum formulation (stay alert chewing gum) via a multiple dosing regimen provides an effective and convenient means of maintaining effective concentrations of caffeine that would in some operational scenarios be desirable for maintaining alertness and performance in sleep deprived individuals.
π SIMILAR VOLUMES
The pharmacokinetics and the dose proportionality of a new anticonvulsant compound, HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) was studied in healthy male volunteers as part of the pharmacological evaluation for new drugs. Study was performed administering doses of 250, 375, 500 and 625 mg of
The multiple-dose pharmacokinetics of the new HI-receptor antagonist, tazifylline, were investigated in healthy volunteers. From single-dose data, tazifylline appeared to be rapidly absorbed (median tm, of 0.6 h) and eliminated (t% 1.0 f 0.2 h). However, plasma levels measured on days 3 and 8 of the
The single-and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover design, each subject received three separate doses: 50,
The pharmacokinetics and dose proportionality of fexofenadine, a new non-sedating antihistamine, and its enantiomers were characterized after single and multiple-dose administration of its hydrochloride salt. A total of 24 healthy male volunteers (31 98 years) received oral doses of 20, 60, 120 and